1. Home
  2. SNY vs LRCX Comparison

SNY vs LRCX Comparison

Compare SNY & LRCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNY
  • LRCX
  • Stock Information
  • Founded
  • SNY 1994
  • LRCX 1980
  • Country
  • SNY France
  • LRCX United States
  • Employees
  • SNY N/A
  • LRCX N/A
  • Industry
  • SNY Biotechnology: Pharmaceutical Preparations
  • LRCX Industrial Machinery/Components
  • Sector
  • SNY Health Care
  • LRCX Technology
  • Exchange
  • SNY Nasdaq
  • LRCX Nasdaq
  • Market Cap
  • SNY 116.5B
  • LRCX 126.4B
  • IPO Year
  • SNY N/A
  • LRCX N/A
  • Fundamental
  • Price
  • SNY $48.61
  • LRCX $101.79
  • Analyst Decision
  • SNY Buy
  • LRCX Buy
  • Analyst Count
  • SNY 2
  • LRCX 25
  • Target Price
  • SNY $62.50
  • LRCX $97.33
  • AVG Volume (30 Days)
  • SNY 2.2M
  • LRCX 9.7M
  • Earning Date
  • SNY 07-31-2025
  • LRCX 07-30-2025
  • Dividend Yield
  • SNY 3.29%
  • LRCX 0.90%
  • EPS Growth
  • SNY 39.56
  • LRCX 32.12
  • EPS
  • SNY 5.45
  • LRCX 3.59
  • Revenue
  • SNY $48,817,552,946.00
  • LRCX $17,135,705,000.00
  • Revenue This Year
  • SNY $3.39
  • LRCX $24.90
  • Revenue Next Year
  • SNY $7.05
  • LRCX $2.41
  • P/E Ratio
  • SNY $8.92
  • LRCX $28.35
  • Revenue Growth
  • SNY N/A
  • LRCX 20.32
  • 52 Week Low
  • SNY $45.80
  • LRCX $56.32
  • 52 Week High
  • SNY $60.12
  • LRCX $113.00
  • Technical
  • Relative Strength Index (RSI)
  • SNY 46.26
  • LRCX 76.82
  • Support Level
  • SNY $47.99
  • LRCX $97.71
  • Resistance Level
  • SNY $49.43
  • LRCX $99.50
  • Average True Range (ATR)
  • SNY 0.58
  • LRCX 1.90
  • MACD
  • SNY 0.18
  • LRCX 0.06
  • Stochastic Oscillator
  • SNY 56.15
  • LRCX 98.80

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

About LRCX Lam Research Corporation

Lam Research is one of the largest semiconductor wafer fabrication equipment manufacturers in the world. It specializes in deposition and etch, which entail the buildup of layers on a semiconductor and the subsequent selective removal of patterns from each layer. Lam holds the top market share in etch and holds the clear second share in deposition. It is more exposed to memory chipmakers for DRAM and NAND chips. It counts as top customers the largest chipmakers in the world, including TSMC, Samsung, Intel, and Micron.

Share on Social Networks: